LONGAVO

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Jun 2023 filing date already counts against anyone who files later.

Record

Serial number

98041822

Mark type

Word mark

Filed

14 Jun 2023

Published for opposition

06 Feb 2024

Attorney of record

Lori Wolfe

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

Owner

• TEVA PHARMACEUTICALS USA, Inc., Parsippany, NJ, US
• TEVA PHARMACEUTICALS USA, Inc., Parsippany, NJ, US

Prosecution history

• 05 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 04 Aug 2026 — SOU EXTENSION 4 GRANTED
• 01 Apr 2026 — SOU EXTENSION 4 FILED
• 03 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 04 May 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
• 04 May 2026 — NOTICE OF REVIVAL - E-MAILED
• 04 May 2026 — PETITION TO REVIVE-GRANTED
• 04 May 2026 — TEAS PETITION TO REVIVE RECEIVED
• 04 May 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 04 May 2026 — ABANDONMENT - NO USE STATEMENT FILED
• 18 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 18 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 18 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 17 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 16 Sept 2025 — SOU EXTENSION 3 GRANTED